E Fund Management (HK)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
451
+158
+54% +$88.6K 0.08% 144
2026
Q1
$165K Buy
293
+76
+35% +$48.7K 0.07% 132
2025
Q4
$139K Buy
217
+157
+262% +$107K 0.05% 141
2025
Q3
$38.3K Buy
60
+23
+62% +$14K 0.02% 124
2025
Q2
$19.8K Sell
37
-77
-68% -$36.8K 0.02% 114
2025
Q1
$48K Sell
114
-50
-30% -$21.7K 0.04% 94
2024
Q4
$68K Buy
164
+106
+183% +$46.5K 0.05% 70
2024
Q3
$29K Buy
58
+57
+5,700% +$27.7K 0.02% 78
2024
Q2
$0 Sell
1
-179
-99% -$89.9K ﹤0.01% 131
2024
Q1
$97K Buy
180
+12
+7% +$6.56K 0.06% 48
2023
Q4
$93K Buy
168
+108
+180% +$50.7K 0.05% 38
2023
Q3
$26K Buy
+60
New +$29.9K 0.02% 47

Other funds holding IDXX

E Fund Management (HK)'s IDXX Position: Q2 2026 in Review

E Fund Management (HK) increased its Idexx Laboratories (IDXX) stake by 54% in Q2 2026, buying an estimated $88.6K and bringing the position to 451 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #144.

E Fund Management (HK) first reported a position in IDXX in Q3 2023 and has held it in 12 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • E Fund Management (HK) held 451 shares of Idexx Laboratories worth $237K as of Q2 2026.
  • E Fund Management (HK) bought 158 Idexx Laboratories shares in Q2 2026, an estimated $88.6K.
  • Idexx Laboratories made up 0.08% of E Fund Management (HK)'s portfolio in Q2 2026, its #144 holding.
  • E Fund Management (HK) first reported a position in Idexx Laboratories in Q3 2023 and has held it in 12 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.